Table 2.
Comparison of clinical indexes of diabetic foot ulcer patients infected with sensitive bacteria and multidrug resistant bacteria
| Index | Infected with Sensitive Bacteria(n = 62) | Infected with Multidrug resistant bacteria(n = 84) | P Value |
|---|---|---|---|
| Sex (M/F) | 41/21 | 52/32 | 0.600 |
| Age | 50.24 ± 8.71 | 49.39 ± 12.29 | 0.643 |
| Diabetes duration (years) | 10.51 ± 6.32 | 9.75 ± 5.94 | 0.458 |
| BMI(kg/m2) | 24.87 ± 3.18 | 30.11 ± 3.61 | 0.000* |
| HbA1c(%) | 7.91 ± 0.85 | 9.82 ± 0.93 | 0.000* |
| FPG(mmol/l) | 9.35 ± 1.74 | 11.51 ± 1.90 | 0.000* |
| TG (mmol/l) | 2.05 ± 1.58 | 2.69 ± 0.92 | 0.003* |
| TC (mmol/l) | 4.67 ± 1.20 | 4.45 ± 0.88 | 0.203 |
| HDL-c (mmol/l) | 1.29 ± 0.45 | 1.31 ± 0.38 | 0.772 |
| LDL-c (mmol/l) | 2.79 ± 0.80 | 2.87 ± 0.78 | 0.546 |
| Ulcer course(Month) | 1.51 ± 0.92 | 2.20 ± 1.26 | 0.000* |
| Ulcer size(cm2) | 15.21 ± 10.41 | 26.12 ± 14.79 | 0.000* |
| Wagners Grade | |||
| I | 2(3.23%) | 4(4.76%) | 0.644 |
| II | 25(40.32) | 31(36.90%) | 0.675 |
| II | 12(19.35%) | 16(19.05%) | 0.963 |
| IV | 23(37.10%) | 33(39.29%) | 0.788 |
| Amorbidities | |||
| Hypertension | 24(38.71%) | 38(45.24%) | 0.430 |
| Retinopathy | 32(51.61%) | 47(55.95%) | 0.603 |
| Peripheral neuropathy | 25(40.32%) | 57(67.86%) | 0.001* |
| Kidney disease | 32(51.61%) | 47(55.95%) | 0.603 |
| Peripheral vascular lesions | 28(45.16%) | 61(72.62%) | 0.001* |
| Osteomyelitis | 5(8.06%) | 24(28.57%) | 0.002* |
| White blood cell count (*103) | 9.21 ± 1.87 | 6.51 ± 1.77 | 0.000* |
| Neutrophil percentage (%) | 50.13 ± 17.61 | 38.42 ± 15.25 | 0.000* |
| Use of antimicrobial drugs within the last 3 months | 36(58.06%) | 64(78.05%) | 0.020* |
Abbreviations: BMI Body mass index, HbA1c Hemoglobin A1c, FPG Fasting plasma glucose, TG Triglyceride, TC Total cholesterol, HDL-C High-density lipoprotein-cholesterol, LDL-C Low-density lipoprotein-cholesterol
Data are expressed as mean ± SD or percentage. *P < 0.05 compared with infected with sensitive bacteria group